- Market Capitalization, $K 9,567,584
- Shares Outstanding, K 1,092,190
- Annual Sales, $ 16,887 M
- Annual Income, $ -998,000 K
- 60-Month Beta 1.48
- Price/Sales 0.57
- Price/Cash Flow 2.25
- Price/Book 0.64
|Period||Period Low||Period High||Performance|
| || |
-0.11 (-1.24%)since 09/29/20
| || |
-3.11 (-26.24%)since 07/29/20
| || |
+0.36 (+4.30%)since 10/29/19
Biosimilars Market is valued at USD 7.49 Billion in 2018 and expected to reach USD 34.39 Billion by 2025 with the CAGR of 24.32% over the forecast period.
, /PRNewswire/ -- Read the full report: Market Segmentation• By Application: Infectious Diseases, Neurology, Cardiovascular, Lifestyle and Endocrinology, Gastroenterology, Other Applications• By...
, /PRNewswire/ -- The report has been added to offering.
New York, New York--(Newsfile Corp. - October 28, 2020) - and would like to discuss your legal rights, click here or call Faruqi & Faruqi partner at or .
New York, New York--(Newsfile Corp. - October 28, 2020) - Rosen Law Firm, a global investor rights law firm, reminds the purchasers of the securities of Teva Pharmaceuticals Industries Limited (NYSE:...
New York, New York--(Newsfile Corp. - October 27, 2020) - and would like to discuss your legal rights, click here or call Faruqi & Faruqi partner at or .
The global influenza medication market size is projected to reach USD 993.7 million by 2026, exhibiting a CAGR of 2.2% during the forecast period. Increasing global burden of influenza will be one of the...
New York, New York--(Newsfile Corp. - October 26, 2020) - and would like to discuss your legal rights, click here or call Faruqi & Faruqi partner at or .
Pomerantz LLP announces that a class action lawsuit has been filed against Teva Pharmaceuticals Industries Limited ("Teva" or the "Company") (NYSE: TEVA) and certain of its officers. The class action,...
The is segmented on the lines of its drug type, route of administration and regional. Basis of drug type is segmented into Acyclovir, Valacyclovir and Famciclovir. Based on route of administration it...
|Teva Pharmaceutical Industries Ltd|
|Pharmaceutical Vaneck ETF|
|GS Activebeta International ETF|
|FTSE RAFI Dev Markets Ex-U.S. Invesco ETF|
|Jpmorgan Betabuilders International Equity ETF|
|Db-Xt MSCI EAFE Hgd Eq|